T. Rowe Price Investment Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230M Sell
1,512,160
-303,582
-17% -$50.6M 0.15% 161
2026
Q1
$381M Buy
1,815,742
+1,815,404
+537,102% +$456M 0.26% 95
2025
Q4
$97K Buy
338
+248
+276% +$77.5K ﹤0.01% 660
2025
Q3
$28K Buy
90
+11
+14% +$3.45K ﹤0.01% 671
2025
Q2
$25K Buy
+79
New +$22.8K ﹤0.01% 670

Other funds holding PODD

T. Rowe Price Investment Management's PODD Position: Q2 2026 in Review

T. Rowe Price Investment Management reduced its Insulet (PODD) stake by 17% in Q2 2026, selling an estimated $50.6M and leaving 1,512,160 shares worth $230M. The position accounts for 0.15% of the portfolio, ranked #161.

T. Rowe Price Investment Management first reported a position in PODD in Q2 2025 and has held it in 5 quarters since. The position peaked at $381M in Q1 2026. 731 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • T. Rowe Price Investment Management held 1,512,160 shares of Insulet worth $230M as of Q2 2026.
  • T. Rowe Price Investment Management sold 303,582 Insulet shares in Q2 2026, an estimated $50.6M.
  • Insulet made up 0.15% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #161 holding.
  • T. Rowe Price Investment Management first reported a position in Insulet in Q2 2025 and has held it in 5 quarters since.
  • T. Rowe Price Investment Management's Insulet position peaked at $381M in Q1 2026.
  • 731 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.